Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;15(2):339-53.
doi: 10.1208/s12249-013-0065-8. Epub 2013 Dec 20.

A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug

Affiliations

A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug

Mohammed M Alvi et al. AAPS PharmSciTech. 2014 Apr.

Abstract

Paracellular route is a natural pathway for the transport of many hydrophilic drugs and macromolecules. The purpose of this study was to prospectively evaluate the ability of novel co-processed non-ionic surfactants to enhance the paracellular permeability of a model hydrophilic drug metformin using Caco-2 (human colonic adenocarcinoma) cell model. A three-tier screen was undertaken to evaluate the co-processed blends based on cytotoxicity, cellular integrity, and permeability coefficient. The relative contribution of the paracellular and the transcellular route in overall transport of metformin by co-processed blends was determined. Immunocytochemistry was conducted to determine the distribution of tight-junction protein claudin-1 after incubation with the co-processed blends. It was found that novel blends of Labrasol and Transcutol-P enhanced metformin permeability by approximately twofold with transient reduction in the transepithelia electrical resistance (TEER) and minimal cytotoxicity compared with the control, with the paracellular pathway as the major route of metformin transport. Maximum permeability of metformin (∼10-fold) was mediated by Tween-20 blends along with >75% reduction in the TEER which was irreversible over 24-h period. A shift in metformin transport from the paracellular to the transcellular route was observed with some Tween-20 blends. Immunocytochemical analysis revealed rearrangement of the cellular borders and fragmentation on treatment with Tween-20 blends. In conclusion, cytotoxicity, cellular integrity, and permeability of the hydrophilic drugs can be greatly influenced by the polyoxyethylene residues and medium chain fatty acids in the non-ionic surfactants at clinically relevant concentrations and therefore should be thoroughly investigated prior to their inclusion in formulations.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Cumulative effect of novel co-processed Labrasol, Transcutol-P, and Tween-20 blends on cytotoxicity, TEER, and Lucifer yellow permeability across Caco-2 cell monolayers after 4 h incubation at 37°C. The data are represented as means ± SD (n = 3)
Fig. 2
Fig. 2
Effect of novel co-processed blends of Labrasol (1A), Transcutol (1B), and Tween-20 (1C) on the TEER of Caco-2 cell monolayers after 4 h incubation at 37°C. The data are represented as means ± SD (n = 3)
Fig. 3
Fig. 3
Lucifer yellow permeability in presence of novel co-processed blends of Labrasol (2A), Transcutol-P (2B), and Tween-20 (2C) across Caco-2 cell monolayers after 4 h incubation at 37°C. HBSS containing 0.5% DMSO was used as a vehicle control. All measurements are expressed as means ± SD (n = 3)
Fig. 4
Fig. 4
Immunostaining of tight junction protein claudin-1 in Caco-2 cell monolayers after 4 h incubation with novel co-processed blends of Labrasol (ad), Transcutol-P (eh), and Tween-20 (il)
Fig. 5
Fig. 5
Effect of novel co-processed Labrasol (a), Transcutol (b), and Tween-20 (c) blends on the TEER following co-incubation with 10 mM metformin across Caco-2 cell monolayers after 4 h incubation at 37°C. The data are represented as means ± SD (n = 3)

References

    1. Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2012;64:280–9. doi: 10.1016/j.addr.2012.09.005. - DOI - PubMed
    1. Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol. 2009;1:1–16. doi: 10.1101/cshperspect.a002584. - DOI - PMC - PubMed
    1. Aungst BJ, Saitoh H, Burcham DL, Huang S, Mousa SA, Hussain MA. Enhancement of the intestinal absorption of peptides and nonpeptides. J Contr Rel. 1996;41(1–2):19–31. doi: 10.1016/0168-3659(96)01353-3. - DOI
    1. Balda M, Whitney JA, Flores C, Gonzalez S, Cereijido M, Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996;134(4):1031–49. doi: 10.1083/jcb.134.4.1031. - DOI - PMC - PubMed
    1. Benet LZ, Broccatelli F, Opera TI. BDDCS applied to over 900 drugs. AAPS J. 2011;13(4):519–47. doi: 10.1208/s12248-011-9290-9. - DOI - PMC - PubMed

LinkOut - more resources